BRPI9713596C1 - novas preparações de medicamentos aquosas para a obtenção de aerossóis livres de gás propelente. - Google Patents

novas preparações de medicamentos aquosas para a obtenção de aerossóis livres de gás propelente.

Info

Publication number
BRPI9713596C1
BRPI9713596C1 BRPI9713596A BR9713596A BRPI9713596C1 BR PI9713596 C1 BRPI9713596 C1 BR PI9713596C1 BR PI9713596 A BRPI9713596 A BR PI9713596A BR 9713596 A BR9713596 A BR 9713596A BR PI9713596 C1 BRPI9713596 C1 BR PI9713596C1
Authority
BR
Brazil
Prior art keywords
drug preparations
aqueous drug
new aqueous
aerosols
free
Prior art date
Application number
BRPI9713596A
Other languages
English (en)
Other versions
BR9713596B8 (pt
BR9713596A (pt
BR9713596B1 (pt
Inventor
Zierenberg Bernd
Freund Bernhard
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7815979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI9713596(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BR9713596A publication Critical patent/BR9713596A/pt
Publication of BR9713596B1 publication Critical patent/BR9713596B1/pt
Publication of BR9713596B8 publication Critical patent/BR9713596B8/pt
Publication of BRPI9713596C1 publication Critical patent/BRPI9713596C1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

patente de invenção: <b>"novas preparações de medicamentos aquosas para a obtenção de aerossóis livres de gás propelente"<d>. a presente invenção se refere a preparação de medicamentos em forma de soluções aquosas para a preparação de aerossóis livres de gás propelente.
BRPI9713596A 1996-12-20 1997-12-16 novas preparações de medicamentos aquosas para a obtenção de aerossóis livres de gás propelente. BRPI9713596C1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19653969A DE19653969A1 (de) 1996-12-20 1996-12-20 Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
PCT/EP1997/007062 WO1998027959A2 (de) 1996-12-20 1997-12-16 Neue wässerige arzneimittelzubereitungen zur erzeugung treibgasfreier aerosole

Publications (4)

Publication Number Publication Date
BR9713596A BR9713596A (pt) 2000-04-04
BR9713596B1 BR9713596B1 (pt) 2013-01-08
BR9713596B8 BR9713596B8 (pt) 2013-02-19
BRPI9713596C1 true BRPI9713596C1 (pt) 2021-05-25

Family

ID=7815979

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9713596A BRPI9713596C1 (pt) 1996-12-20 1997-12-16 novas preparações de medicamentos aquosas para a obtenção de aerossóis livres de gás propelente.

Country Status (39)

Country Link
US (3) US20010008632A1 (pt)
EP (2) EP1230916A3 (pt)
JP (1) JP4659160B2 (pt)
KR (1) KR100496723B1 (pt)
CN (1) CN1097455C (pt)
AR (1) AR008721A1 (pt)
AT (1) ATE235887T1 (pt)
AU (1) AU740543B2 (pt)
BG (1) BG64433B1 (pt)
BR (1) BRPI9713596C1 (pt)
CA (1) CA2275392C (pt)
CO (1) CO4920211A1 (pt)
DE (2) DE19653969A1 (pt)
DK (1) DK0946146T3 (pt)
EE (1) EE03949B1 (pt)
EG (1) EG23981A (pt)
ES (1) ES2196388T3 (pt)
HK (1) HK1022846A1 (pt)
HR (1) HRP970694B1 (pt)
HU (2) HU227012B1 (pt)
ID (1) ID22481A (pt)
IL (1) IL130464A (pt)
MY (1) MY124547A (pt)
NO (1) NO320652B1 (pt)
NZ (1) NZ336825A (pt)
PE (1) PE32899A1 (pt)
PL (1) PL189511B1 (pt)
PT (1) PT946146E (pt)
RS (1) RS49803B (pt)
RU (1) RU2219906C2 (pt)
SA (1) SA97180756B1 (pt)
SI (1) SI0946146T1 (pt)
SK (1) SK282910B6 (pt)
TR (1) TR199901408T2 (pt)
TW (1) TW438605B (pt)
UA (1) UA64736C2 (pt)
UY (1) UY24813A1 (pt)
WO (1) WO1998027959A2 (pt)
ZA (1) ZA9711370B (pt)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DE19808295A1 (de) 1998-02-27 1999-11-11 Boehringer Ingelheim Int Behälter für eine medizinische Flüssigkeit
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
DE19940713A1 (de) 1999-02-23 2001-03-01 Boehringer Ingelheim Int Kartusche für eine Flüssigkeit
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP2004509920A (ja) * 2000-09-29 2004-04-02 ボード　オブ　トラスティーズ　オペレーティング　ミシガン　ステート　ユニヴァーシティ カテコールアミン医薬組成物および方法
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
EP1335729A2 (de) * 2000-10-31 2003-08-20 Boehringer Ingelheim Pharma GmbH & Co.KG Inhalative lösungsformulierung mit einem tiotropiumsalz
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
EP1837021A3 (de) * 2000-10-31 2008-03-19 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalative Lösungsformulierung mit einem Tiotropiumsalz
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
DE10136555A1 (de) 2001-07-27 2003-02-13 Boehringer Ingelheim Int Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren
EP1661570A3 (en) * 2001-09-18 2012-10-24 Nycomed Danmark ApS Compositions comprising ipatropium and xylometazoline for treatment of the common cold
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
WO2003037317A1 (en) * 2001-10-26 2003-05-08 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt
WO2003092654A1 (en) 2002-05-02 2003-11-13 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US20050220720A1 (en) * 2002-05-02 2005-10-06 David Edwards Formulations limiting spread of pulmonary infections
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
CN1674887A (zh) * 2002-08-14 2005-09-28 贝林格尔英格海姆法玛两合公司 含抗胆碱能剂的吸入用的气雾剂制剂
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US20050107417A1 (en) * 2003-07-28 2005-05-19 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a betamimetic
US20050042176A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a steroid
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050059643A1 (en) * 2003-08-05 2005-03-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a steroid and a betamimetic
DE102004001451A1 (de) * 2004-01-08 2005-08-11 Boehringer Ingelheim International Gmbh Vorrichtung zum Haltern eines fluidischen Bauteiles
US20050203088A1 (en) * 2004-01-09 2005-09-15 Boehringer Ingelheim International Gmbh Medicament combinations based on scopine- or tropene acid esters with EGFR-kinase inhibitors
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
CN1997900B (zh) 2004-05-25 2010-10-13 埃内尔迪斯特里布齐恩公司 用于检测任意未知相电压相对于参考相电压的相配线的方法和装置
WO2005123064A1 (en) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Adrenergic complement inhaler comprising compounds such as ascorbates tocopherols or polycaboxylic acid chelators
US8627821B2 (en) * 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
EA016072B1 (ru) * 2005-05-18 2012-01-30 Палметрикс Инк. Применение состава соли кальция для изменения биофизических свойств слизистой оболочки
ES2530991T3 (es) 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedimiento para la obtención de betamiméticos
AU2006311060A1 (en) * 2005-11-09 2007-05-18 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
WO2007134965A1 (de) * 2006-05-19 2007-11-29 Boehringer Ingelheim International Gmbh Aerosolformulierung enthaltend ipratropiumbromid und salbutamolsulfat
EP2026785A1 (de) 2006-05-19 2009-02-25 Boehringer Ingelheim International GmbH Treibgasfreie aerosolformulierung für die inhalation enthaltend ipratropiumbromid und salbutamolsulfat
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
WO2009035712A1 (en) * 2007-09-13 2009-03-19 Medtronic, Inc. Medical electrical profiled lead
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012030664A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
WO2012030645A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
ES2899621T3 (es) 2010-09-29 2022-03-14 Pulmatrix Operating Co Inc Polvos secos catiónicos que comprenden sal de magnesio
IL286573B (en) 2010-09-29 2022-08-01 Pulmatrix Operating Co Inc Monovalent metallic cation dry powders for inhalation
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
EP2704724B1 (en) * 2011-05-03 2016-10-26 Chiesi Farmaceutici S.p.A. Improved suspension formulation of beclometasone dipropionate for administration by inhalation
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013130767A1 (en) 2012-02-29 2013-09-06 Pulmatrix, Inc. Inhalable dry powders
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
CN105324106A (zh) 2013-04-01 2016-02-10 普马特里克斯营业公司 噻托铵干粉
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
UA121114C2 (uk) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Небулайзер, індикаторний пристрій і контейнер
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
JP6782706B2 (ja) * 2015-05-18 2020-11-11 グレンマーク・スペシャルティー・エスエー 噴霧用のチオトロピウム吸入用溶液
CN109925300A (zh) * 2017-12-19 2019-06-25 北京盈科瑞创新药物研究有限公司 一种福多司坦雾化吸入用溶液制剂及其制备方法
AU2021314977A1 (en) 2020-07-31 2023-03-02 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
GB8825892D0 (en) * 1988-11-04 1988-12-07 Fisons Plc Pharmaceutical composition
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
WO1992006726A1 (en) * 1990-10-16 1992-04-30 Mayor Pharmaceutical Laboratories, Inc. Vitamin-mineral treatment methods and compositions
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
KR100392280B1 (ko) * 1995-06-27 2003-11-19 베링거 인겔하임 카게 추진제비함유흡입성에어로졸을제조하기위한안정한추진제비함유약제학적용액
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19536916A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Kg Inhalative Applikation von 2-Amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol, insbesondere seines (-)-Enantiomeren, sowie deren pharmakologisch verträgliche Säureadditionssalze
DE19620509A1 (de) * 1996-05-22 1997-11-27 Hoechst Ag Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
EP0808627A2 (de) * 1996-05-22 1997-11-26 Hoechst Aktiengesellschaft Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
DE19644646A1 (de) * 1996-10-26 1998-04-30 Mann & Hummel Filter Filter, insbesondere zur Filtrierung des Schmieröls einer Brennkraftmaschine
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US20060239930A1 (en) * 1997-08-04 2006-10-26 Herbert Lamche Process for nebulizing aqueous compositions containing highly concentrated insulin
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt

Also Published As

Publication number Publication date
YU28499A (sh) 2001-09-28
JP4659160B2 (ja) 2011-03-30
SI0946146T1 (en) 2003-10-31
RS49803B (sr) 2008-06-05
DK0946146T3 (da) 2003-04-22
EE9900307A (et) 2000-02-15
EE03949B1 (et) 2003-02-17
DE59709722D1 (de) 2003-05-08
BR9713596B8 (pt) 2013-02-19
HRP970694B1 (en) 2005-06-30
BG64433B1 (en) 2005-02-28
NO320652B1 (no) 2006-01-09
NO993004D0 (no) 1999-06-18
AU5663698A (en) 1998-07-17
WO1998027959A2 (de) 1998-07-02
MY124547A (en) 2006-06-30
EP0946146B1 (de) 2003-04-02
BR9713596A (pt) 2000-04-04
HUP0000520A2 (hu) 2000-09-28
AR008721A1 (es) 2000-02-09
PL189511B1 (pl) 2005-08-31
EP0946146A2 (de) 1999-10-06
AU740543B2 (en) 2001-11-08
HUP0000520A3 (en) 2000-10-30
EP1230916A2 (de) 2002-08-14
HU228494B1 (en) 2013-03-28
DE19653969A1 (de) 1998-06-25
HK1022846A1 (en) 2000-08-25
CO4920211A1 (es) 2000-05-29
EP1230916A3 (de) 2003-02-05
CA2275392C (en) 2004-06-29
BR9713596B1 (pt) 2013-01-08
TW438605B (en) 2001-06-07
ZA9711370B (en) 1998-06-22
NO993004L (no) 1999-06-18
JP2001507343A (ja) 2001-06-05
HU0600044D0 (en) 2006-03-28
PT946146E (pt) 2003-08-29
ATE235887T1 (de) 2003-04-15
CN1240347A (zh) 2000-01-05
SA97180756B1 (ar) 2006-04-28
HRP970694A2 (en) 1998-10-31
KR20000057683A (ko) 2000-09-25
CN1097455C (zh) 2003-01-01
UY24813A1 (es) 2000-09-29
HU227012B1 (en) 2010-04-28
EG23981A (en) 2008-02-27
WO1998027959A3 (de) 1998-08-13
US20010008632A1 (en) 2001-07-19
BG103482A (en) 2000-01-31
IL130464A (en) 2004-12-15
KR100496723B1 (ko) 2005-06-22
ID22481A (id) 1999-10-21
SK81499A3 (en) 2000-01-18
TR199901408T2 (xx) 1999-08-23
SK282910B6 (sk) 2003-01-09
NZ336825A (en) 2001-09-28
PE32899A1 (es) 1999-04-23
PL334185A1 (en) 2000-02-14
ES2196388T3 (es) 2003-12-16
UA64736C2 (uk) 2004-03-15
US20090185983A1 (en) 2009-07-23
CA2275392A1 (en) 1998-07-02
RU2219906C2 (ru) 2003-12-27
IL130464A0 (en) 2000-06-01
US20090099225A1 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
BRPI9713596C1 (pt) novas preparações de medicamentos aquosas para a obtenção de aerossóis livres de gás propelente.
BR0214469A (pt) 17alfa-alquil-17beta-óxi-estratrienos e produtos intermediários para sua preparação, aplicação dos 17alfa-alquil-17beta-óxi-estratrienos para a preparação de medicamentos bem como preparações farmacêuticas
NO976084D0 (no) Ny, stabil legemiddeltilberedning for dannelse av drivgassfrie aerosoler
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
ME00330B (me) Jednodnevne formulacije oksikodona
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
YU84703A (sh) Oralni rastvor aripiprazola
GB9914486D0 (en) Medicaments
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
BR0111266A (pt) Sìntese reduzida de derivados de 3,3-diarilpropilamina
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
SE0102440D0 (sv) New compound
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
ES2062137T3 (es) Utilizacion de 5&#39;-deoxi-5&#39;-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
YU87501A (sh) Farmaceutski kompleksi
ES2170649B1 (es) Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
EE200300065A (et) Meetod peptiidsoolade valmistamiseks, nende peptiidsoolade kasutamine ning neid peptiidsooli sisaldavad farmatseutilised preparaadid
AR026243A1 (es) Solucion oral de galantamina
NO910186L (no) Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat.
PL362650A1 (en) Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them
TR200301552A1 (tr) Rofekoksib&#39; in yeni oral farmakolojik formülasyonları.
BR9914125A (pt) Composições farmacêuticas baseadas em alfa-ciclodextrina para administração oral de análogos lh-rh
ECSP972345A (es) Nuevas preparaciones medicamentosas acuosas para la produccion de aerosoles libres de gas propulsor
ECSP003424A (es) NUEVAS COMPOSICIONES DE MEDICAMENTOS A BASE DE COMPUESTOS ANTICOLINERGICAMENTE ACTIVOS Y ß-MIMETICOS

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/01/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2192 DE 08/01/2013, QUANDO AO ITEM 51.

B17A Notification of administrative nullity (patentee has 60 days time to reply to this notification)

Free format text: REQUERENTE DA NULIDADE: LIBBS FARMACEUTICA LTDA.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/12/1997 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 16/12/2017